IV Synercid
November 1999
Rhone-Poulenc Rorer is now marketing IV Synercid in the States...it's still investigational in Canada.
Synercid is the new antibiotic of "last resort"...for vancomycin-resistant Enterococcus faecium (VREF).
It's actually a combination of quinupristin and dalfopristin...the first antibiotics in the streptogramin class.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive